Back to Journals » International Journal of Nanomedicine » Volume 6

Grafting of a novel gold(III) complex on nanoporous MCM-41 and evaluation of its toxicity in Saccharomyces cerevisiae

Authors Fazaeli Y, Amini MM, Ashourion H, Heydari H, Majdabadi A, Jalilian AR, Abolmaali S

Published 12 December 2011 Volume 2011:6 Pages 3251—3257

DOI https://doi.org/10.2147/IJN.S25449

Review by Single-blind

Peer reviewer comments 2

Yousef Fazaeli1,2, Mostafa M Amini1, Hamed Ashourion3, Homayoun Heydari2, Abbas Majdabadi2, Amir Reza Jalilian2, Shamsozoha Abolmaali2,3
1Department of Chemistry, Faculty of Sciences, Shahid Beheshti University, Evin, Tehran, 2Agricultural, Medical and Industrial Research School, Moazzen Boulevard, Rajaee Shahr, Karaj, 3Department of Biotechnology, Faculty of New Technologies and Engineering, Shahid Beheshti University, Evin, Tehran, Iran

Abstract: The goal of this research was to investigate the potential of newly synthesized gold complex trichloro(2,4,6-trimethylpyridine)Au(III) as an anticancer agent. The gold(III) complex was synthesized and grafted on nanoporous silica, MCM-41, to produce AuCl3@PF-MCM-41 (AuCl3 grafted on pyridine-functionalized MCM-41). The toxicity of trichloro(2,4,6-trimethylpyridine)Au(III) and AuCl3@PF-MCM-41 in Saccharomyces cerevisiae (as a model system) was studied. The gold(III) complex showed a mid cytotoxic effect on yeast viability. Using the drug delivery system, nanoporous MCM-41, the gold(III) complex became a strong inhibitor for growth of yeast cells at a very low concentration. Furthermore, the animal tests revealed a high uptake of AuCl3@PF-MCM-41 in tumor cells. The stability of the compound was confirmed in human serum.

Keywords: trichloro(2,4,6-trimethylpyridine)Au(III), MCM-41, Au(III), Saccharomyces cerevisiae, anticancer agent

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Protein encapsulation in polymeric microneedles by photolithography

Kochhar JS, Zou S, Chan SY, Kang L

International Journal of Nanomedicine 2012, 7:3143-3154

Published Date: 22 June 2012

Gd2O3 nanoparticles in hematopoietic cells for MRI contrast enhancement

Hedlund A, Ahrén M, Gustafsson H, Abrikossova N, Warntjes M, Jönsson JI, Uvdal K, Engström M

International Journal of Nanomedicine 2011, 6:3233-3240

Published Date: 9 December 2011

Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups

Hong SC, Lee JH, Lee J, Kim HY, Park JY, Cho J, Lee J, Han DW

International Journal of Nanomedicine 2011, 6:3219-3231

Published Date: 7 December 2011

Preparation of hippurate-zinc layered hydroxide nanohybrid and its synergistic effect with tamoxifen on HepG2 cell lines

Hussein Al Ali SH, Al-Qubaisi M, Hussein MZ, Zainal Z, Hakim MN

International Journal of Nanomedicine 2011, 6:3099-3111

Published Date: 1 December 2011

Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects

Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW

International Journal of Nanomedicine 2011, 6:2821-2835

Published Date: 9 November 2011

New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell

Kashanian S, Hemati Azandaryani A, Derakhshandeh K

International Journal of Nanomedicine 2011, 6:2393-2401

Published Date: 1 November 2011

Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes

Samadikhah HR, Majidi A, Nikkhah M, Hosseinkhani S,

International Journal of Nanomedicine 2011, 6:2275-2283

Published Date: 12 October 2011

Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo

Zhao JH, Ji L, Wang H, Chen ZQ, Zhang YT, Liu Y, Feng NP

International Journal of Nanomedicine 2011, 6:1611-1619

Published Date: 9 August 2011

New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles

de Azevedo MB, Tasic L, Fattori J, Rodrigues FH, Cantos FC, Ribeiro LP, de Paula V, Ianzer D, Santos RA

International Journal of Nanomedicine 2011, 6:1005-1016

Published Date: 15 May 2011